Current progress of adeno-associated-virus-based therapy for the treatment of cystic fibrosis in humans

R. Bryan Sutton Department of Cell Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, TX

DOI: https://doi.org/10.12746/swrccc.v6i23.461

Keywords: Cystic fibrosis, CFTR, adeno-associated virus, gene therapy

Download data is not yet available.

Nirenberg W. Will Society Be Prepared? 1966: Research

Corporation for Science Advancement. Research Corporation

Award Dinner.

Bordignon C, Notarangelo LD, Nobili N, et al. Gene therapy

in peripheral blood lymphocytes and bone marrow for

ADA-immunodeficient patients. Science 1995;270:470–75.

Sibbald B. Death but one unintended consequence of

gene-therapy trial. CMAJ 2001;164:1612.

Kim WO. Institutional review board (IRB) and ethical issues

in clinical research. Korean J Anesth 2012;62:3–12.

Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of

AAV serotypes 1-9 mediated gene expression and tropism in

mice after systemic injection. Mol Ther 2008;16:1073–1080.

Schultz BR, Chamberlain JS. Recombinant adeno-associated

virus transduction and integration. Mol Ther 2008;16:

–1199.

Moss RB, Milla C, Colombo J, et al. Repeated aerosolized

AAV-CFTR for treatment of cystic fibrosis: a randomized

placebo-controlled phase 2B trial. Hum Gene Ther 2007;18:

–732.

Flotte T, Carter B, Conrad C, et al. A phase I study of an

adeno-associated virus-CFTR gene vector in adult CF patients

with mild lung disease. Hum Gene Ther 1996;7:1145–1159.

Loring HS, ElMallah MK, Flotte TR. Development of rAAV2-

CFTR: History of the First rAAV Vector Product to be Used

in Humans. Hum Gene Ther Methods 2016;27:49–58.

Flotte TR, Schwiebert EM, Zeitlin PL, Carter BJ, Guggino WB.

Correlation between DNA transfer and cystic fibrosis airway epithelial

cell correction after recombinant adeno-associated virus

serotype 2 gene therapy. Hum Gene Ther 2005;16:921–928.

Moss RB, Rodman D, Spencer LT, et al. Repeated adenoassociated

virus serotype 2 aerosol-mediated cystic fibrosis

transmembrane regulator gene transfer to the lungs of

patients with cystic fibrosis: a multicenter, double-blind,

placebo-controlled trial. Chest 2004;125:509–521.

FDA. Approved Cellular and Gene Therapy Products. 2018.

GeneTherapyProducts/ApprovedProducts/default.htm.